Proteogenomic characterization of MiT family translocation renal cell carcinoma
Yuanyuan Qu(First Affiliated Hospital of Shihezi University Medical College), Chen Ding(Fudan University), Yang Liu(Fudan University), Shujuan Ni(Shanghai Medical College of Fudan University), Jinwen Feng(Fudan University), Aihetaimujiang Anwaier(Fudan University Shanghai Cancer Center), Dalong Cao(Fudan University), Xiaohui Wu(Fudan University), Xi Tian(Ministry of Education), Xiaoru Pei(Fudan University), Guohai Shi(Shanghai Medical College of Fudan University), Lin Bai(Peking University), Yue Wang(Fudan University), Jian‐Yuan Zhao(Shanghai Jiao Tong University), Wenhao Xu(Shanghai Jiao Tong University), Hailiang Zhang(Sun Yat-sen University), Menghong Sun, Guojian Yang(Fudan University), Dingwei Ye(Fudan University), Jiaqi Su(Shanghai Medical College of Fudan University), Hualei Gan(Fudan University Shanghai Cancer Center), Yu Zhu(Kunming University of Science and Technology), Fujiang Xu(Affiliated Hospital of Southwest Medical University)
Cited by 72
Related Papers
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
|International Journal of Cancer|2009|979
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2020|786
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5
|Journal of Hematology & Oncology|2018|371